Ann Woolfrey
Professor
Pediatrics
Fred Hutchinson Cancer Rearch Center
United States of America
Biography
Ann E. Woolfrey, MD, is attending physician at Seattle Children’s Hospital and associate member of the Clinical Research Division at Fred Hutchinson Cancer Research Center (FHCRC). She is director of the Unrelated Marrow Donor Program for the Seattle Cancer Care Alliance. Nationally, she serves on the Board of Directors of the National Marrow Donor Program (NMDP), and is a member of the Cord Blood Advisory Group and of the Histocompatibility Advisory Group for the NMDP; in addition, she serves on the National Steering Committee of the Radiation Injury Treatment Network, the Center for International Bone Marrow Transplant Research (CIBMTR) Physician Taskforce, the CIBMTR Pediatric Transplant Steering committee, the Pediatric Bone Marrow Transplant Clinical Trials Network (PBMT-CTN) Nonmalignant disease commity, and the PBMT-CTN Cellular Therapy committee.
Research Interest
Dr. Woolfrey’s research interests involve pediatric oncology, particularly leukemia, and processes of stem cell, blood and marrow transplant. She is involved in several studies on overcoming genetic barriers in hematopoietic stem cell transplant, identifying non-myeloablative transplants for nonmalignant disorders and investigating the use of blood stem cell and marrow transplant from HLA-compatible related and unrelated donors
Publications
-
Gutman JA, Leisenring W, Appelbaum FR, Woolfrey AE, Delaney C Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis. 19660726 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation , 2009 Sept. : 1122-9
-
Kalaycio ME, Kukreja M, Woolfrey AE, Szer J, Cortes J, Maziarz RT, Bolwell BJ, Buser A, Copelan E, Gale RP, Gupta V, Maharaj D, Marks DI, Pavletic SZ, Horowitz MM, Arora M Allogeneic hematopoietic cell transplant for prolymphocytic leukemia. 19961946 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation , 2010 Apr, : 543-7
-
Nemecek ER, Guthrie KA, Sorror ML, Wood BL, Doney KC, Hilger RA, Scott BL, Kovacsovics TJ, Maziarz RT, Woolfrey AE, Bedalov A, Sanders JE, Pagel JM, Sickle EJ, Witherspoon R, Flowers ME, Appelbaum FR, Deeg HJ Conditioning with Treosulfan and Fludarabine Followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies. 20685259 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation , 2010 May 25
-
Burroughs LM, Torgerson TR, Storb R, Carpenter PA, Rawlings DJ, Sanders J, Scharenberg AM, Skoda-Smith S, Englund J, Ochs HD, Woolfrey AE Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. 20643476 The Journal of allergy and clinical immunology , 2010 July 17
-
Brunstein CG, Gutman JA, Weisdorf DJ, Woolfrey AE, Defor TE, Gooley TA, Verneris MR, Appelbaum FR, Wagner JE, Delaney C Allogeneic hematopoietic cell transplantation for hematological malignancy: relative risks and benefits of double umbilical cord blood. 20686119 Blood , 2010 Aug. 4
